Effects of corticotrophin-releasing factor receptor 1 antagonists on amyloid-β and behavior in Tg2576 mice
Open accessThe DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Abstract
Previous studies indicate that psychosocial stressors could accelerate amyloid-β (Aβ) levels and accelerate plaque deposition in mouse models of Alzheimer disease (AD). Stressors enhanced the release of corticotrophin-releasing factor (CRF), and exogenous CRF administration mimicked the effects of stress on Aβ levels in mouse models of AD. However, whether CRF receptor 1 (CRF1) antagonists could influence the stress-induced acceleration of an AD-like process in mouse models has not been well studied. We sought to examine whether CRF1 antagonists inhibit the effects of isolation stress on tissue Aβ levels, Aβ plaque deposition, and behaviors related to anxiety and memory in Tg2576 mice, and to investigate the molecular mechanism underlying such effects. Cohorts of Tg2576 mouse pups were isolated or group-housed at 21 days of age, and then the subgroups of these cohorts received daily intraperitoneal injections of the CRF1 antagonists, antalarmin or R121919 (5, 10, and 20 mg/kg), or vehicle for 1 week. Other cohorts of Tg2576 mouse pups were isolated or group-housed at 21 days of age, and then at 4 months of age, subgroups of these mice were administered antalarmin (20 mg/kg) or vehicle in their drinking water for 6 months. Finally, cultured primary hippocampal neurons from regular Tg2576 pups (P0) were incubated with CRF (0.1, 1, and 10 nM), antalarmin (100 nM) or H-89 (1 μM) for 48 h. Brain tissues or cultured neurons were collected for histological and biochemical analyses, and behavioral measures were collected in the cohorts of mice that were chronically stressed. Administration of antalarmin at 20 mg/kg dose for 1 week significantly reduced Aβ1-42 levels in isolation stressed mice. Administration of antalarmin for 6 months significantly decreased plasma corticosterone levels, tissue Aβ1-42 levels, and Aβ plaque deposition in the brain and blocked the effects of isolation stress on behaviors related to anxiety and memory. Finally, incubation of neurons with 100 nM antalarmin inhibited the ability of 10 nM CRF to increase Aβ1-42 levels and protein kinase A IIβ expression. The effect of CRF1 on Aβ1-42 levels was also diminished by treatment with H-89, a c-AMP/PKA inhibitor. These results suggest that CRF1 antagonists can slow an AD-like process in Tg2576 mice and that the c-AMP/PKA signaling pathway may be involved in this effect.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Plasma Cortisol and Progression of Dementia in Subjects With Alzheimer-Type Dementia
Csernansky, J. G., Dong, H., Fagan, A. M., Wang, L., Xiong, C., Holtzman, D. M., & Morris, J. C. (2006) · American Journal of Psychiatry · doi:10.1176/appi.ajp.163.12.2164 · Cited by 426 · cited 2×
“Stress has been increasingly recognized as an external factor that can impact the onset and progression of AD (Dong et al. 2004; Wilson et al. 2006; Csernansky et al. 2006; Huang et al. 2010; Alkadhi 2012).”
BackgroundSelf-citationDong, H., Goico, B., Martin, M., Csernansky, C. A., Bertchume, A., & Csernansky, J. G. (2004) · Neuroscience · doi:10.1016/j.neuroscience.2004.05.040 · Cited by 342 · cited 4×
“Stress has been increasingly recognized as an external factor that can impact the onset and progression of AD (Dong et al. 2004; Wilson et al. 2006; Csernansky et al. 2006; Huang et al. 2010; Alkadhi 2012).”
BackgroundMethodInfluentialSelf-citationProtein kinase C overactivity impairs prefrontal cortical regulation of working memory
Birnbaum, S. G., Yuan, P. X., Wang, M., Vijayraghavan, S., Bloom, A. K., Davis, D. J., Gobeske, K. T., Sweatt, J. D., Manji, H. K., & Arnsten, A. F. T. (2004) · Science · doi:10.1126/science.1100021 · Cited by 318
Ungless, M. A., Singh, V., Crowder, T. L., Yaka, R., Ron, D., & Bonci, A. (2003) · Neuron · doi:10.1016/s0896-6273(03)00461-6 · Cited by 297
The role of G protein-coupled receptors in the pathology of Alzheimer's disease
Thathiah, A., & De Strooper, B. (2011) · Nature Reviews Neuroscience · doi:10.1038/nrn2977 · Cited by 288
Funk, C. K., Zorrilla, E. P., Lee, M.-J., Rice, K. C., & Koob, G. F. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.03.063 · Cited by 276
Self-citationChronic Psychological Distress and Risk of Alzheimer’s Disease in Old Age
Wilson, R. S., Arnold, S. E., Schneider, J. A., Kelly, J. F., Tang, Y., & Bennett, D. A. (2006) · Neuroepidemiology · doi:10.1159/000095761 · Cited by 266 · cited 2×
“Stress has been increasingly recognized as an external factor that can impact the onset and progression of AD (Dong et al. 2004; Wilson et al. 2006; Csernansky et al. 2006; Huang et al. 2010; Alkadhi 2012).”
BackgroundBinneman, B., Feltner, D., Kolluri, S., Shi, Y., Qiu, R., & Stiger, T. (2008) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2008.07071199 · Cited by 254
Kang, J.-E., Cirrito, J. R., Dong, H., Csernansky, J. G., & Holtzman, D. M. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0700148104 · Cited by 219 · cited 4×
“CRF and CRF receptor 1 (CRF1) play critical roles in regulation of stress-induced neuropathogenesis and behavioral deficits in mouse models of AD (Kang et al. 2007; Dong et al. 2008; Carroll et al. 2011; Rissman et al. 2012).”
BackgroundMethodInfluentialMitani, Y., Yarimizu, J., Saita, K., Uchino, H., Akashiba, H., Shitaka, Y., Ni, K., & Matsuoka, N. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.4264-11.2012 · Cited by 203 · cited 1×
“Spontaneous alternation (Mitani et al. 2012; Hsiao et al. 1996).”
Cited by
The CRF system as a therapeutic target for neuropsychiatric disorders
Sanders, J., & Nemeroff, C. (2016) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2016.09.004 · Cited by 72
Neuronal calcineurin transcriptional targets parallel changes observed in Alzheimer disease brain
Hopp, S. C., Bihlmeyer, N. A., Corradi, J. P., Vanderburg, C., Cacace, A. M., Das, S., Clark, T. W., Betensky, R. A., Hyman, B. T., & Hudry, E. (2018) · Journal of Neurochemistry · doi:10.1111/jnc.14469 · Cited by 20
Daulatzai, M. A. (2015) · Neurotoxicity Research · doi:10.1007/s12640-015-9528-x · Cited by 12
“…(Schmidt and Duman 2007; Masi and Brovedani 2011) and increases in phospho-tau (Elliott et al. 1993; Cuadrado-Tejedor et al. 2012; Rissman et al. 2012) and Ab (Dong and Csernansky 2009; Dong et al. 2008, 2014; Cuadrado-Tejedor et al. 2012) in the hippocampus may accelerate the process of AD.”
Background
Metadata
- Authors
- Dong, H., Wang, S., Zeng, Z., Li, F., Montalvo-Ortiz, J., Tucker, C., Akhtar, S., Shi, J., Meltzer, H. Y., Rice, K. C., & Csernansky, J. G.
- Venue
- Psychopharmacology
- Published
- 2014-05-27
- Volume
- 231
- Issue
- 24
- Pages
- 4711-4722
- ISSN
- 0033-3158 (ISSN-L)
- 1432-2072
- OpenAlex
- W1989767966
- Cited by
- 42
- References
- 12
- FWCI
- 2.53
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Effects of corticotrophin-releasing factor receptor 1 antagonists on amyloid-β and behavior in Tg2576 mice. https://app.cochat.ai/papers/10.1007/s00213-014-3629-8
- The paper
- Dong, H., Wang, S., Zeng, Z., Li, F., Montalvo-Ortiz, J., Tucker, C., Akhtar, S., Shi, J., Meltzer, H. Y., Rice, K. C., & Csernansky, J. G. (2014). Effects of corticotrophin-releasing factor receptor 1 antagonists on amyloid-β and behavior in Tg2576 mice. Psychopharmacology. https://doi.org/10.1007/s00213-014-3629-8
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.